Leigh Farrell

Dr Farrell brings over 30 years of leadership experience across the biotechnology, pharmaceutical and medical technology sectors. Most recently, Dr Farrell served as Head of Health Security Systems Australia (a division of DMTC Ltd). Prior to this, he held senior US-based roles as Senior Vice President, Commercial at Certara USA, Inc. His experience spans senior positions at Biota Pharmaceuticals, GBS Venture Partners and Johnson & Johnson Research. Dr Farrell currently serves as a Non-Executive Director of ASX-listed Pro Medicus Limited (ASX: PME) and holds board positions with Ena Respiratory Pty Limited and Axelia Oncology Pty Limited. He is also an Advisory Board Member at Medicines Australia and is a Committee Member on the Walter & Eliza Hall Institute, Medical Research Board Commercialisation Committee. He is also the past Chair of the Medical Countermeasures Products Australia, an unincorporated public-private partnership between Departments of Health and Aged Care, Defence Department, Defence Science and Technology Group, CSIRO, industry and academia.